Back
53
Day Range
$45.05
$46.06
52-Week Range
$29.66
$47.86
Volume
3,312,388
50D / 200D Avg
$43.70
/
$38.65
Prev Close
$45.36
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 25.4 | 0.4 |
| P/B | 3.0 | 2.9 |
| ROE % | 11.5 | 3.8 |
| Net Margin % | 32.4 | 3.9 |
| Rev Growth 5Y % | 1.0 | 10.0 |
| D/E | 1.4 | 0.2 |
Key Takeaways
Revenue grew 0.96% annually over 5 years — modest growth
Earnings declined -10.25% over the past year
ROE of 11.49% — decent returns on equity
Net margin of 32.42% shows strong profitability
Generating 2.49B in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 4.10%
Growth
Revenue Growth (5Y)
0.96%
Revenue (1Y)5.06%
Earnings (1Y)-10.25%
FCF Growth (3Y)-8.71%
Quality
Return on Equity
11.49%
ROIC7.58%
Net Margin32.42%
Op. Margin65.58%
Safety
Debt / Equity
1.38
Current Ratio0.97
Interest Coverage5.07
Valuation
P/E Ratio
25.35
P/B Ratio3.02
EV/EBITDA17.87
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5.06% | Revenue Growth (3Y) | 0.50% |
| Earnings Growth (1Y) | -10.25% | Earnings Growth (3Y) | -17.58% |
| Revenue Growth (5Y) | 0.96% | Earnings Growth (5Y) | 5.61% |
| Profitability | |||
| Revenue (TTM) | 2.38B | Net Income (TTM) | 770.95M |
| ROE | 11.49% | ROA | 3.93% |
| Gross Margin | 100.00% | Operating Margin | 65.58% |
| Net Margin | 32.42% | Free Cash Flow (TTM) | 2.49B |
| ROIC | 7.58% | FCF Growth (3Y) | -8.71% |
| Safety | |||
| Debt / Equity | 1.38 | Current Ratio | 0.97 |
| Interest Coverage | 5.07 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 25.35 | P/B Ratio | 3.02 |
| P/S Ratio | 8.22 | PEG Ratio | 1.04 |
| EV/EBITDA | 17.87 | Dividend Yield | 0.02% |
| Market Cap | 19.54B | Enterprise Value | 27.87B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.38B | 2.26B | 2.35B | 2.24B | 2.29B |
| Net Income | 770.95M | 858.98M | 1.13B | 42.83M | 619.73M |
| EPS (Diluted) | 1.80 | 1.45 | 2.53 | 0.10 | 1.49 |
| Gross Profit | 2.38B | 2.26B | 2.35B | 2.24B | 2.29B |
| Operating Income | 1.56B | 1.29B | 1.49B | 307.07M | 1.43B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 19.62B | 18.22B | 16.38B | 16.81B | 17.52B |
| Total Liabilities | 9.91B | 7.88B | 6.30B | 7.29B | 7.27B |
| Shareholders' Equity | 6.48B | 6.95B | 6.53B | 5.63B | 5.78B |
| Total Debt | 8.95B | 7.61B | 6.14B | 7.12B | 7.10B |
| Cash & Equivalents | 618.70M | 929.03M | 477.01M | 1.71B | 1.54B |
| Current Assets | 619.00M | 1.80B | 1.27B | 2.55B | 2.88B |
| Current Liabilities | 636.21M | 1.25B | 161.38M | 1.17B | 171.25M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#346 of 1024
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026